14 - 20 April 2018
These are links to news stories from the last week that may be of interest to people in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts
Plan to extend personal health budgets
The government has announced plans to extend the eligibility for personal health budgets in England. These budgets give people the control of some of the treatment they receive. The plans are currently out to public consultation until 8 June
MS Trust link: Personal health budgets
Ocrevus (ocrelizumab) a year on
A survey of people in America who have been taking Ocrevus in the year since it was approved in the USA found that half of respondents said they felt an improvement in symptoms. Nearly half said they had no long-lasting side effects. People who didn't find the drug effective were more likely to report side effects.
Source: MS News Today
MS Trust link: Ocrevus (ocrelizumab)
Differences in cognition for people with SPMS
People with MS have lower cognition scores than people who don't have the condition according to a small study. People with secondary progressive MS had lower scores then people with relapsing remitting MS - particularly with 'mental flexibility' and learning new information
MS Trust link: Cognition and cognitive symptoms